ArticleCost effectiveness and resource allocation : C/E2026
The cost-effectiveness of second line diabetes medication added to standard therapy in preventing type 2 diabetes related nephropathy in Germany.
Hanni Hille et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.